HUP0001531A3 - Anthranilic acid derivatives as multi drug resistance modulators - Google Patents

Anthranilic acid derivatives as multi drug resistance modulators

Info

Publication number
HUP0001531A3
HUP0001531A3 HU0001531A HUP0001531A HUP0001531A3 HU P0001531 A3 HUP0001531 A3 HU P0001531A3 HU 0001531 A HU0001531 A HU 0001531A HU P0001531 A HUP0001531 A HU P0001531A HU P0001531 A3 HUP0001531 A3 HU P0001531A3
Authority
HU
Hungary
Prior art keywords
acid derivatives
drug resistance
anthranilic acid
multi drug
resistance modulators
Prior art date
Application number
HU0001531A
Other languages
English (en)
Original Assignee
Xenova Ltd Slough
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd Slough filed Critical Xenova Ltd Slough
Publication of HUP0001531A2 publication Critical patent/HUP0001531A2/hu
Publication of HUP0001531A3 publication Critical patent/HUP0001531A3/hu

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
HU0001531A 1996-10-18 1997-10-17 Anthranilic acid derivatives as multi drug resistance modulators HUP0001531A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9602552 1996-10-18

Publications (2)

Publication Number Publication Date
HUP0001531A2 HUP0001531A2 (hu) 2000-08-28
HUP0001531A3 true HUP0001531A3 (en) 2000-09-28

Family

ID=10788338

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001531A HUP0001531A3 (en) 1996-10-18 1997-10-17 Anthranilic acid derivatives as multi drug resistance modulators

Country Status (3)

Country Link
CN (1) CN100354265C (hu)
HU (1) HUP0001531A3 (hu)
ZA (1) ZA979329B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60326341D1 (de) * 2002-05-14 2009-04-09 Xenova Ltd Verfahren zur herstellung von anthranilsäurederivat-hydrat
WO2013030100A1 (de) * 2011-08-26 2013-03-07 Bayer Intellectual Property Gmbh Verfahren zur herstellung von tetrazol-substituierten anthranilsäurediamid-derivaten durch umsetzung von benzoxazinonen mit aminen
CN102603630B (zh) * 2012-03-12 2014-08-20 北京科技大学 邻氨基苯甲酸磺酰化衍生物及其制备方法和应用
US20160194299A1 (en) * 2013-05-24 2016-07-07 The California Institute For Biomedical Research Compounds for treatment of drug resistant and persistent tuberculosis
CN104434947B (zh) * 2014-11-07 2016-11-09 滨州医学院附属医院 一种抗胆管癌的药物组合物及其应用
CN104910069B (zh) * 2014-12-15 2018-03-23 北京科技大学 氨茴酸类衍生物、其制备方法及其在医药上的用途
CN112724124A (zh) * 2021-01-18 2021-04-30 林剑雄 4-羟基喹啉类衍生物及其制备方法和在抗肿瘤药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE152443T1 (de) * 1992-07-10 1997-05-15 Glaxo Lab Sa Anilide-derivate
AU5813394A (en) * 1992-12-23 1994-07-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellated uracil derivates
GB9426224D0 (en) * 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
CN100354265C (zh) 2007-12-12
HUP0001531A2 (hu) 2000-08-28
ZA979329B (en) 1999-04-19
CN1241181A (zh) 2000-01-12

Similar Documents

Publication Publication Date Title
AU4400797A (en) Colon selective drug delivery composition
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU1071301A (en) Pharmaceutical compounds
HU9801044D0 (en) Sulfonyl-amino-carboxylic acid derivatives
HUP0003881A3 (en) Amidocarboxylic acid derivatives
AU1267400A (en) Pharmaceutical moxifloxacin preparation
AU6062498A (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use
AU1559199A (en) Isothiazolcarboxylic acid derivatives
AU1409100A (en) Drugs
AU8591898A (en) Pharmaceutical compounds
AU7904998A (en) Pharmaceutical composition containing peptichemio
HUP0001531A3 (en) Anthranilic acid derivatives as multi drug resistance modulators
AU9343098A (en) Pharmaceutical composition
AU6940998A (en) Phospholipid drug derivatives
AUPQ365299A0 (en) Anthranilic acid derivatives
AU5722900A (en) Pharmaceutical compounds
AUPP332898A0 (en) Pharmaceutical composition
AU6480299A (en) Pharmaceutical compounds
AU732214C (en) Biphenyl derivatives and drug composition
AU1688099A (en) Pharmaceutical preparation
HUP0101341A3 (en) New drug combinations
AU5490298A (en) Syringe
HUP0004132A3 (en) Rapidly soluble drug composition
AU5429699A (en) Drug targeting
AU5184599A (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished